Curex Pharma Private Limited

Curex Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U33100DL2015PTC278835 Incorporated 08 April 2015 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹6.46 Cr
▼ 8.00% YoY
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Open charges
₹53.8 Lakh
Satisfied ₹62.25 Lakh
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
Brands
1
Associated brands

About Curex Pharma Private Limited

Data last updated:

Curex Pharma Private Limited is a private limited company based in New, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 April 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2015PTC278835. Its GSTIN is 07AAGCC0110N1ZY (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ram Pher Tiwari and Sarvesh Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10 G 10th Floor, Gopala Tower 25 Rajendra Place, New, Delhi, India – 110008.

As per the financials filed for FY 2024, the company reported a revenue of ₹6.46 Cr, a decline of 8% compared to the previous year.

The company is associated with 1 brand: Curex Pharma. As per MCA filings, the company has open charges of ₹53.8 Lakh and satisfied charges of ₹62.25 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website curexgroup.in.

Company Details of Curex Pharma Private Limited
CIN U33100DL2015PTC278835
Registration Number 278835
Incorporation Date 08 April 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    10 G 10th Floor, Gopala Tower 25 Rajendra Place, New, Delhi, India – 110008
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Curex Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Curex Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Curex Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Curex Pharma

Curex Pharma operates one associated brand: Curex Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
A CDMO focused on manufacturing active pharmaceutical ingredients.curexgroup.in

Competitors & Alternatives of Curex Pharma

Brands and companies operating in the same space as Curex Pharma Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

CompetitorDescriptionLocationFounded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology companyHyderabad, India, India2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured.Indore, India, India2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured.Beijing, China, China2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered.Dudley, United Kingdom, United Kingdom2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals.Marseille, France, France1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research.Mumbai, India, India1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service providerCambridge, United States, United States2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas.Bengaluru, India, India2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.Noida, India, India1978

Business Activity of Curex Pharma

The main business activity of Curex Pharma is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details for Curex Pharma Private Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Curex Pharma

Curex Pharma Private Limited is audited by KUMAR RAKESH & ASSOCIATES for the financial year 2019.

NameStatusAppointment DateCessation Date
KUMAR RAKESH & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history for Curex Pharma Private Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Curex Pharma Private Limited

Curex Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ram Pher TiwariDirector25 Apr 20224 Years 5 MonthsCurrent
Sarvesh KumarDirector25 Apr 20224 Years 5 MonthsCurrent

Financials of Curex Pharma Private Limited FY 2025 filings available

Curex Pharma Private Limited reported revenue of ₹6.46 Cr (down 8.00% YoY) for FY 2024.

Revenue · FY 2024
₹6.46 Cr ▼ 8.00%
Premium access

Ten-year financial statements for Curex Pharma Private Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Curex Pharma

Premium access

Shareholding and ownership data for Curex Pharma Private Limited

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Curex Pharma

Open charges
₹53.8 Lakh
Satisfied charges
₹62.25 Lakh
Breakdown by lending institutions
Others₹0.55 Cr
Hdfc Bank Limited₹0.07 Cr
Latest charge details
DateLenderAmountStatus
27 Jul 2022Hdfc Bank Limited₹7 LakhSatisfied
01 Jun 2020Others₹8.45 LakhSatisfied
20 Nov 2019Others₹46.8 LakhSatisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Curex Pharma

Employment history and EPFO contributions of people linked to Curex Pharma.

Premium access

Employee and EPFO history for Curex Pharma Private Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Curex Pharma

Curex Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAGCC0110N1ZYDelhiActive01 Jul 2017
06AAGCC0110N1Z0HaryanaActive22 Mar 2021
Premium access

GST registrations and filing compliance for Curex Pharma Private Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Curex Pharma

Premium access

Credit ratings, litigation, and regulatory alerts for Curex Pharma Private Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Curex Pharma

Premium access

MSME payment history for Curex Pharma Private Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Curex Pharma

Premium access

Corporate group structure for Curex Pharma Private Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Curex Pharma

Premium access

MCA filings and documents for Curex Pharma Private Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Curex Pharma

Charges
06 Nov 2025
A charge registered on 27 Jul 2022 via Charge ID 100633767 with Hdfc Bank Limited was fully satisfied on 06 Nov 2025.
Charges
06 Nov 2025
A charge registered on 20 Nov 2019 via Charge ID 100312581 with Others was fully satisfied on 06 Nov 2025.
Activity
30 Sep 2025
Curex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Curex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
06 Jun 2024
A charge registered on 01 Jun 2020 via Charge ID 100345589 with Others was fully satisfied on 06 Jun 2024.
Charges
27 Jul 2022
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Lakh with Charge ID 100633767 was registered on 27 Jul 2022.

Frequently Asked Questions about Curex Pharma Private Limited

Curex Pharma is an active private limited company based in New, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 April 2015 (11+ years old) and is registered under CIN U33100DL2015PTC278835.

Curex Pharma reported revenue of ₹6.46 Cr for FY 2024 (down 8.00% YoY).

Curex Pharma has 2 current directors:

The GSTIN of Curex Pharma is 07AAGCC0110N1ZY, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAGCC0110N1Z0 (Haryana).

The CIN (Corporate Identification Number) of Curex Pharma is U33100DL2015PTC278835. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Curex Pharma was incorporated on 08 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.

Curex Pharma can be reached through the website curexgroup.in. Its registered office is in New, Delhi, India.

The registered office of Curex Pharma is at 10 G 10th Floor, Gopala Tower 25 Rajendra Place, New, Delhi, India – 110008.

Curex Pharma has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹2 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available